Therefore, while IL-10 can suppress NK cell functions, therapeutic disruption of IL-10 signaling for enhancement of adoptive NK cell transfer must be carefully considered in the particular cancer context, whereas disruption of TGFβ is more likely to have broad beneficial effects on adoptive NK cell therapy. This evidence concerns the gene TGFB1 and cancer.